Researchers make cancer immunotherapy ‘breakthrough’
4 March 2016 | By Victoria White
Researchers have found the tools necessary to give immunotherapy the precision guidance that patients with cancer so desperately need...
List view / Grid view
News
AMRA Profiler to be added to GE Healthcare MRI scanners
3 March 2016 | By Victoria White
AMRA Profiler is a cloud-based body composition measurement service, which uses images from a rapid, 6-minute MRI scan to deliver accurate, precise fat and muscle measurements...
ADHD medication associated with decreased bone density in children
3 March 2016 | By Victoria White
Results from a large study indicate that children on ADHD medication had lower bone mineral density in the femur, femoral neck and lumbar spine...
Xultophy cost-effective versus current basal insulin intensification treatments
3 March 2016 | By Victoria White
New findings show that Xultophy is cost-effective versus current insulin intensification treatment options for the treatment of people in the UK with type 2 diabetes...
Palbociclib plus fulvestrant slows breast cancer spread
3 March 2016 | By Victoria White
In a study, some 67% of 347 women given palbociclib plus fulvestrant showed clinical benefit compared with 40% of 174 women given placebo plus fulvestrant...
First patient dosed in Phase 3 iclaprim ABSSSI trial
2 March 2016 | By Victoria White
Iclaprim is being developed for the treatment of the most common and serious bacterial infections such as acute bacterial skin and skin structure infections...
MAA submitted for haemophilia A treatment, Adynovi
2 March 2016 | By Victoria White
Adynovi is an extended circulating half-life recombinant Factor VIII treatment, for paediatric, adolescent and adult patients with haemophilia A...
Amgen submits sBLA for Blincyto to the FDA
2 March 2016 | By Victoria White
The sBLA includes new data supporting the treatment of paediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL)...
Phase II trial of sulfatinib in thyroid cancer starts
2 March 2016 | By Victoria White, Digital Content Producer
The trial will evaluate sulfatinib in locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer or medullary thyroid cancer....
Breast cancer treatment pipeline has over 1,000 drugs in development
1 March 2016 | By Victoria White
The breast cancer treatment pipeline’s exceptional levels of activity and innovation may significantly alter the clinical and commercial landscape, says GBI Research...
MAA submitted for tivozanib for the treatment of RCC
1 March 2016 | By Victoria White
Tivozanib is an oral, once-daily, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI)...
FDA approves Gazyva to treat follicular lymphoma
1 March 2016 | By Victoria White
The FDA has approved Gazyva (obinutuzumab) plus bendamustine chemotherapy followed by Gazyva alone as a new treatment for people with follicular lymphoma...
Quotient Clinical showcases Enabled-First-in-Human® programs at ASCPT 2016
1 March 2016 | By Quotient Clinical
Quotient Clinical will be showcasing its Enabled-First-in-Human® programs at the upcoming ASCPT Meeting 2016...
ProStrakan reaches deal for Moventig with AstraZeneca
1 March 2016 | By Victoria White
ProStrakan will make an upfront payment to AstraZeneca of $70 million to acquire the rights to Moventig in the EU, Iceland, Norway, Switzerland and Liechtenstein...
CHMP adopts positive opinion of afatinib in SqCC
29 February 2016 | By Victoria White
The CHMP positive opinion is based on the results of the head-to-head LUX-Lung 8 trial in patients with SqCC...
